Jordan L Lacoste

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Atrial Fibrillation

Percutaneous Coronary Intervention

St Segment Elevation Myocardial Infarction

Top Venues

Journal of pharmacy practice

American journal of cardiovascular drugs : drugs, devices, and other interventions

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan W Bok, Jordan L Lacoste, Wei Fang, Kazuhiko Kido
Impact of Outpatient Beta Blocker Therapy Adjustment on Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction Admitted for Acute Decompensated Heart Failure. Journal of pharmacy practice (2024)
Thomas W Szymanski, Matthew R Rockhold, Jordan L Lacoste
Temporal Effect of CYP3A4/5 Induction on Ticagrelor's Pharmacodynamic Effects: A Case Series. Journal of pharmacy practice (2024)
Jordan L Lacoste, Thomas W Szymanski, Juan Carlo Avalon, Galen Kabulski, Utkarsh Kohli, Nassir Marrouche, Atul Singla, Sudarshan Balla, Arshad Jahangir
Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies. American journal of cardiovascular drugs : drugs, devices, and other interventions 22 (5) (2022)
Cavan P O'Kane, Juan Carlo O Avalon, Jordan L Lacoste, Wei Fang, Christopher M Bianco, Laura Davisson, Kara L Piechowski
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m2. Pharmacotherapy (2021)